Clinical and Molecular Hepatology

Clinical and Molecular Hepatology is the quarterly open access journal of the Korean Association for the Study of the Liver, published in English and tracing its origins to 1995, covering clinical and molecular research on liver disease, with a 2025 Journal Impact Factor of 21.7《临床与分子肝病学》是（Korean Association for the Study of the Liver）（KASL）出版的季刊开放获取期刊，以英文出版，其历史可追溯至 1995 年，涵盖肝病的临床与分子研究，2025 年影响因子为 21.7。

Scope

• It is an international, peer-reviewed, open access journal published quarterly in English该刊是国际性同行评审开放获取期刊，以英文按季出版。
• It aims to share advanced and latest knowledge on hepatobiliary diseases and to provide a wide open academic forum for debate among clinicians, translational researchers and basic scientists该刊致力于分享肝胆疾病的前沿知识，为临床医生、转化研究者与基础科学家提供开放的学术讨论平台。
• It covers viral hepatitis, steatotic liver disease including MASLD and MetALD, cirrhosis, liver transplantation and hepatocellular carcinoma其内容涵盖病毒性肝炎、包括（MASLD）与（MetALD）在内的脂肪性肝病、肝硬化、肝移植与肝细胞癌。
• It improves public health through a multidisciplinary approach and reaches doctors and health professionals worldwide该刊以多学科路径促进公共健康，并触达全球医生与卫生专业人员。
• It publishes original research, reviews, editorials and KASL clinical practice guidelines该刊刊载原创研究、综述、社论与（KASL）临床实践指南。
• All articles are freely available in electronic form at the journal's website under a non-commercial open license全部文章均可在该刊网站以电子形式免费获取，采用非商业开放许可。

History

• The journal began in 1995 as The Korean Journal of Hepatology, publishing ten review articles in Korean and one original article in English该刊于 1995 年以（The Korean Journal of Hepatology）之名创刊，当年发表 10 篇韩文综述与 1 篇英文原创论文。^[1]
• Its language policy changed to English-only in 2010其语言政策于 2010 年改为仅用英文。
• Its title was changed to Clinical and Molecular Hepatology in 2012其刊名于 2012 年更改为《临床与分子肝病学》。
• It was indexed in MEDLINE in 2002 and entered the Science Citation Index Expanded in November 2019该刊于 2002 年被（MEDLINE）收录，并于 2019 年 11 月进入（Science Citation Index Expanded）。
• It is the official journal of the Korean Association for the Study of the Liver该刊是（Korean Association for the Study of the Liver）（KASL）的官方期刊。
• Its impact factor moved from 8.337 in 2022 and 16.9 in 2024 to 21.7 in 2025其影响因子由 2022 年的 8.337、2024 年的 16.9 变化到 2025 年的 21.7。
• In the 2025 Journal Citation Reports it ranks sixth among 153 journals in gastroenterology and hepatology在 2025 年期刊引证报告中，该刊在胃肠病学与肝病学类别的 153 种期刊中位列第六。

Editors

• Its Editor-in-Chief is Won Kim, Professor of Internal Medicine at Seoul National University College of Medicine in Korea现任主编为 Won Kim，韩国首尔大学医学院内科学教授。
• The Deputy Editor is Dong Hyun Sinn副主编为 Dong Hyun Sinn。
• Previous Editors-in-Chief include Jin Wook Kim (2014-2015) and Seung Up Kim (2020-2023)历任主编包括 Jin Wook Kim（2014-2015）与 Seung Up Kim（2020-2023）。
• Won Kim is a clinical and translational researcher focusing on multi-omics and precision medicine in steatotic liver diseaseWon Kim 长期从事脂肪性肝病的多组学与精准医学临床与转化研究。
• As Editor-in-Chief he emphasises research rigour, interdisciplinary collaboration, clinical translation, global engagement and methodological innovation作为主编，他强调研究严谨性、跨学科协作、临床转化、全球参与与方法学创新。
• The journal is supported by an expanded international editorial board该刊由不断扩大的国际编委会支持。